Indegene announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs. As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their transformation. This move aligns with Indegene`s purpose: to enable healthcare organizations to be future-ready by combining deep medical expertise with fit-for purpose technology. Powered by Capital Market - Live News

Net profit of Indegene rose 22.27% to Rs 91.70 crore in the quarter ended September 2024 as against Rs 75.00 crore during the previous quarter ended September 2023. Sales rose 8.04% to Rs 686.80 crore in the quarter ended September 2024 as against Rs 635.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales686.80635.70 8 OPM %18.3619.05 - PBDT143.50120.40 19 PBT124.10100.60 23 NP91.7075.00 22 Powered by Capital Market - Live News

Indegene will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live News

Indegene announced that the 26th Annual General Meeting (AGM) of the company will be held on 6 September 2024.Powered by Capital Market - Live News

Net profit of Indegene rose 28.22% to Rs 87.70 crore in the quarter ended June 2024 as against Rs 68.40 crore during the previous quarter ended June 2023. Sales rose 11.36% to Rs 676.50 crore in the quarter ended June 2024 as against Rs 607.50 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales676.50607.50 11 OPM %19.0515.93 - PBDT139.70112.70 24 PBT119.6092.50 29 NP87.7068.40 28 Powered by Capital Market - Live News